...
首页> 外文期刊>Materials science & engineering >Homoleptic and heteroleptic silver(Ⅰ) complexes bearing diphosphane and thioamide ligands: Synthesis, structures, DNA interactions and antibacterial activity studies
【24h】

Homoleptic and heteroleptic silver(Ⅰ) complexes bearing diphosphane and thioamide ligands: Synthesis, structures, DNA interactions and antibacterial activity studies

机译:轴承二磷酸和硫代酰胺配体的复合物:合成,结构,DNA相互作用和抗菌活性研究

获取原文
获取原文并翻译 | 示例

摘要

Three silver(I) complexes bearing different combinations of diphosphanes and N-heterocyclic thioamides or thioamidates as ligands have been synthesized and structurally characterized: the ionic, homoleptic compound [Ag(xantphos)(2)][BF4] (1), where xantphos = 4,5-bis(diphenylphosphano)-9,9-dimethyl-xanthene, and the neutral, heteroleptic compounds [Ag(xantphos)(kappa-S-pymt)] (2), where pymt = pyrimidine-2-thiolate, and [AgCl (dppbz)(kappa-S-mtdztH)] (3), where dppbz = bis(diphenylphosphano)benzene and mtdztH = 5-methyl-1,3,4-thiadiazole-2-thione. X-ray crystallography studies reveal tetrahedral coordination environments around the silver (I) ions in compounds 1 and 3, while a trigonal planar arrangement of the P2S donor set has been found around the metal center in compound 2. The interaction of the three compounds with calf-thymus DNA was monitored by UV-vis spectroscopy, DNA-viscosity measurements and indirectly by testing their ability to compete with ethidium bromide for DNA intercalation sites studied by fluorescence emission spectroscopy. Intercalation was revealed as the most possible binding mode for the neutral compounds 2 and 3 and electrostatic interactions for the cationic complex [Ag(xantphos)(2)](+) in 1. Complexes 1-3 have also been found to display moderate in vitro antibacterial activity against the Gram-positive B. cereus, S. aureus and the Gram-negative E. coli bacterial strains, with the homoleptic bis-phosphane silver(I) compound 1 exhibiting a lower activity than the other two neutral compounds.
机译:已经合成了三种银(I)轴承二膦和N-杂环硫代酰胺或硫代酰胺的组合物作为配体的组合,并在结构上表征:离子,经杂化合物[Ag(Xantphos)(2)] [BF4](1),其中Xantphos = 4,5-双(二苯基膦膦)-9,9-二甲基 - x吨和中性,异致剂化合物[Ag(XANTPHOS)(Kappa-S-Pymt)](2),其中Pymt =嘧啶-2-硫醇, [AgCl(DPPBZ)(Kappa-S-MTDZTH)](3),其中DPPBZ =双(二苯基膦酰基)苯和MTDZTH = 5-甲基-1,3,4-噻二唑-2-倍硫基。 X射线晶体学研究揭示了化合物1和3中银(I)离子周围的四面体配位环境,而P2S供体组的三角形平面布置已经在化合物2中的金属中心围绕金属中心发现。三种化合物的相互作用通过UV-Vis光谱,DNA粘度测量和间接监测CALF-胸腺DNA,通过测试其与荧光发射光谱研究的DNA插入位点与溴化乙锭进行竞争的能力。嵌入被揭示为中性化合物2和3的最可能结合模式,并且阳离子复合物[Ag(Xantphos)(2)](+)的静电相互作用也被发现在1-3中发现了中度抗革兰氏阳性B.癌症,金黄色葡萄球菌和革兰氏阴性大肠杆菌细菌菌株的体外抗菌活性,具有比其他两个中性化合物的较低活性的较低活性的浓度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号